No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Encompass Health Purchases Land in St. Augustine, Florida

Announces Plans for Future Inpatient Rehabilitation Hospital

Editor: What To Know

  • The Company’s Florida footprint currently includes 12 inpatient rehabilitation hospitals, a hospital under construction in north Tampa, a planned hospital in Pensacola and 19 home health locations.
  • “Provided in a hospital setting, Encompass Health’s services are tailored to meet each patient’s complex needs and help them regain the strength and confidence they need to return to their community at their highest level of independence.
  • Encompass Health notes the planned hospital, once opened, will become part of Encompass Health’s national network of inpatient rehabilitation hospitals and home health and hospice agencies.

July 10, 2020

Encompass Health Corp. announced it has purchased land located at the northwest corner of Silver Lane and Highway 207 in St. Augustine, Florida for the future development of a 40-bed inpatient rehabilitation hospital to serve patients recovering from debilitating illnesses and injuries.

Encompass Health notes the planned hospital, once opened, will become part of Encompass Health’s national network of inpatient rehabilitation hospitals and home health and hospice agencies. The Company’s Florida footprint currently includes 12 inpatient rehabilitation hospitals, a hospital under construction in north Tampa, a planned hospital in Pensacola and 19 home health locations. A construction timeline for the hospital has not yet been established.

“This new, state-of-the-art hospital will help meet a growing need for intensive physical rehabilitative services in the St. Augustine area,” said Linda Wilder, president of Encompass Health’s southeast region. “Provided in a hospital setting, Encompass Health’s services are tailored to meet each patient’s complex needs and help them regain the strength and confidence they need to return to their community at their highest level of independence.”

Services at Encompass Health inpatient rehabilitation hospitals complement those provided by local acute care hospitals. Offering 24-hour nursing care, physical, occupational and speech therapies, and a multi–specialty medical staff, the hospitals treat patients recovering from strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy